A review of intravenous immunoglobulin in the treatment of neuroimmune conditions, acute COVID-19 infection, and post-acute sequelae of COVID-19 Syndrome.
Coronavirus Literature
Publication date: Oct 08, 2024 Intravenous immunoglobulin (IVIG) is an immunomodulatory therapy that has been studied in several neuroimmune conditions, such as Guillain-BarrcE9 Syndrome, chronic inflammatory demyelinating polyneuropathy, multifocal motor ... Read more